This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
R. R. Aparasu , J. R. Mort and H. Brandt (2003). Psychotropic prescription use by community-dwelling elderly in the United States. Journal of the American Geriatrics Society, 51, 671–677.
J. S. Bell , M. Väänänen , H. Ovaskainen , U. Närhi and M. S. Airaksinen (2007). Providing patient care in community pharmacies: practice and research in Finland. Annals of Pharmacotherapy, 41, 1039–1046.
J. S. Bell , T. Klaukka , J. Ahonen and S. Hartikainen (2009). National utilization of transdermal fentanyl among community-dwelling older people in Finland. American Journal of Geriatric Pharmacotherapy, 7, 355–361.
E. R. Dorsey , A. Rabbani , S. A. Gallagher , R. M. Conti and G. C. Alexander (2010). Impact of FDA black box advisory on antipsychotic medication use. Archives of Internal Medicine, 170, 96–103.
B. Draper and K. Berman (2008). Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly. Drugs and Aging, 25, 501–519.
M. F. Folstein , S. E. Folstein and P. R. McHugh (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
C. B. Fox , A. K. Treadway , A. T. Blaszczyk and R. B. Sleeper (2009). Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly. Pharmacotherapy, 29, 383–397.
S. Hartikainen , T. Rahkonen , H. Kautianen and R. Sulkava (2003). Kuopio 75+ study: does advanced age predict more common use of psychotropics among the elderly? International Clinical Psychopharmacology, 18, 163–167.
S. A. Hartikainen , P. Mantyselka , K. Louhivuori-Laako , H. Enlund and R. Sulkava (2005). Concomitant use of analgesics and psychotropics in home-dwelling elderly people – Kuopio 75+ study. British Journal of Clinical Pharmacology, 60, 306–310.
S. Hartikainen , E. Lönnroos and K. Louhivuori (2007). Medication as a risk factor for falls: critical systematic review. Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 62, 1172–1181.
S. N. Hilmer , A. J. McLachlan and D. G. Le Couteur (2007). Clinical pharmacology in the geriatric patient. Fundamental and Clinical Pharmacology, 21, 217–230.
J. Jyrkkä , H. Enlund , M. J. Korhonen , R. Sulkava and S. Hartikainen (2009). Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs and Aging, 26, 494–503.
M. P. Lawton and E. M. Brody (1969). Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist, 9, 179–186.
T. A. Linjakumpu , S. A. Hartikainen , T. J. Klaukka , H. J. Koponen , S-L. Kivela and R. E. Isoaho (2002). Psychotropics among the home dwelling elderly: increasing trends. International Journal of Geriatric Psychiatry, 17, 874–883.
N. Pokela , J. S. Bell , K. Lihavainen , R. Sulkava and S. Hartikainen (2010). Analgesic use among community-dwelling people aged 75 years and older: a population-based interview study. American Journal of Geriatric Pharmacotherapy, 8, 233–244.
M. Rikala , S. Hartikainen , R. Sulkava and M. J. Korhonen (2010a). Validity of the Finnish Prescription Register for measuring psychotropic drug exposures among elderly Finns: a population-based intervention study. Drugs and Aging, 27, 337–349.
M. Salonoja , M. Salminen , P. Aarnio , T. Vahlberg and S. L. Kivelä (2010). One-time counselling decreases the use of benzodiazepines and related drugs among community-dwelling older persons. Age and Ageing, 39, 313–319.
L. S. Schneider (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine, 355, 1525–1538.
J. Snowdon and R. Fleming (2008). Recognising depression in residential facilities: an Australian challenge. International Journal of Geriatric Psychiatry, 23, 295–300.
A. Soudry , C. Dufouil , K. Ritchie , J. F. Dartigues , C. Tzourio and A. Alpérovitch (2008). Factors associated with changes in antidepressant use in a community-dwelling elderly cohort: the Three-City Study. European Journal of Clinical Pharmacology, 64, 51–59.
P. van Vliet , R. C. van der Mast , M. van den Broek , R. G. Westendorp and A. J. de Craen (2009). Use of benzodiazepines, depressive symptoms and cognitive function in old age. International Journal of Geriatric Psychiatry, 24, 500–508.
H. Verdoux , M. Tournier and B. Bégaud (2010). Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatrica Scandinavica, 121, 4–10.
N. Watanabe (2010). Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis. CNS Drugs, 24, 35–53.
J. A. Yesavage (1982–1983). Development and validation of a geriatric depression screening scale: a preliminary report. Journal of Psychiatric Research, 17, 37–49.